MEASURING TREATMENT PROGRESS IN THERAPEUTIC COMMUNITIES

这是对NIDA科学家发展奖(SDA)的申请。 候选人：大卫·克雷塞尔博士在纽约州立大学获得社会学博士学位 研究生中心于1992年10月成立。从那时起，克雷塞尔博士一直致力于 作为治疗社区中心的首席研究助理 国家发展研究院的研究(CTCR)。 (NDRI)他一直在研究药物滥用的“准备情况” 治疗、治疗中的滞留和治疗效果。 环境：研究地点，NDRI的CTCR提供了丰富、多样的 和刺激的环境。NDRI拥有30多名博士学位 科学家们在1993年进行了20多项基金资助。这个 候选人将接受乔治·德勒万的指导、培训和支持， 将担任教官的博士。德莱昂博士是CTCR的主任和 TC研究领域的国际公认权威。 研究；主要研究目的是进行实证调查 进入治疗社区(TC)治疗过程。在颁奖结束前 应聘者将提供现场测试，心理测量方面的改进 通过TC治疗对客户进展的经验性衡量。这将是 通过在三个TC地点进行两项试点研究来完成。这些 测量将在新出现的 康复和治疗阶段理论。 职业发展；应聘者将获得研究科学和 在获奖期间通过参加两个主要项目的管理技能 研究努力。第一个将是广泛的二次分析 从以下地点收集的9800多名受试者的客户治疗准备数据 12吸毒者的特殊人群，包括妇女和种族/族裔 少数民族参与了18个不同的研究项目。第二个项目将 从实验上评估制导仪器的影响 将决策与三种面向TC的模式匹配/转介：长期 住宅(至少12个月)；短期住宅(3-9个月)和 非居民待遇。为继续研究治疗过程提供资金 超过获奖期后，候选人将提交一份提案以验证 新的治疗进度标准涉及更广泛的治疗 医疗模式和客户群体。 意义：两项拟议的先导研究的研究结果 将为一项更大规模的计划研究提供经验基础 应聘者现场测试几种治疗进度仪 治疗社区计划网站。这次实地测试的结果将是 由这些计划用于治疗计划和评估。更多 总的来说，SDA将为专注于 促进对药物治疗的了解的系统研究倡议 进程。这位候选人打算让他的研究大大增加 并为提高科技文献质量做出实际贡献 药物滥用治疗。需要使用过程工具来解决 提高治疗保留率与建立配对的几个问题 在病人和治疗方式之间。

This is a request for a NIDA Scientist Development Award (SDA). Candidate: Dr. David Kressel received his Ph.D. in sociology at the CUNY Graduate Center in October 1992. Since then Dr. Kressel has been working as Principal Research Associate at the Center for Therapeutic Community Research (CTCR) at National Development and Research Institutes, Inc. (NDRI) where he has been studying "readiness" for substance abuse treatment, retention in treatment and treatment efficacy. Environment: The research location, CTCR at NDRI provides a rich, diverse and stimulating environment. NDRI houses more than 30 Ph.D. level scientists, who in 1993, conducted more than 20 funded grants. The candidate will receive guidance, training and support from George De Lewon, ph.D. who will act as preceptor. Dr. De Leon is CTCR's Director and an internationally acknowledged authority in the field of TC research. Research; The major research aim is to conduct an empirical investigation into therapeutic community (TC) treatment process. By the end of the award period the candidate will provide field tested, psychometrically refined empirical measures of client progress through TC treatment. This will be accomplished by conducting two pilot studies at three TC locations. These measurements will be developed within a framework of newly emerging recovery and treatment stage theories. Career Development; The candidate will acquire research science and management skills during the award period by participating in two major research efforts. The first will be an extensive secondary analysis of client readiness for treatment data collected on over 9800 subjects from 12 special population of drug abusers including women and racial/ethnic minorities in 18 different research projects. The second project will experimentally evaluate the impact of an instrument for guiding matching/referral decisions to three TC oriented modalities: long term residential (at least 12 months); short term residential (3-9 months) and non-residential treatment. To fund continued study of treatment process beyond the award period the candidate will submit a proposal to validate the new treatment progress scales involving a wider range of treatment modalities and client populations. Significance: The research finding from the two proposed pilot studies will provide the empirical basis for a basis for a larger planned study by the candidate to field test treatment progress instruments in several therapeutic community program sites. Results form this field test will be utilized by these programs for treatment planning and assessment. More broadly, the SDA will provide the foundation for a career focused on systematic research initiatives to advance understanding of drug treatment process. The candidate intends for his research to add substantially to the scientific literature and make practical contributions to improving substance abuse treatment. Process instrumentation is needed to address issues of enhancing retention in treatment and establishing the match between client and treatment modalities.